1. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis [published online February 28 2013]. Lancet. doi:10.1016/S0140-6736(12)62129-1.
2. Poon SH, Sim K, Sum MY, et al. Evidence-based options for treatment-resistant adult bipolar disorder patients. Bipolar Disord. 2012;14(6):573-584.
3. Hori H, Yamamoto N, Fujii T, et al. Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals [published online September 6, 2012]. Sci Rep. 2012;2:634.-doi:10.1038/srep00634.
4. Roussos P, Bitsios P, Giakoumaki SG, et al. CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals [published online September 17, 2012]. Psychiatry Res. doi:10.1016/j.psychres.2012.08.039.
